image
scPharmaceuticals Inc. SCPH
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.41
-7.66 %
$ 121 M
Market Cap
-1.2
P/E
BALANCE SHEET
108 M ASSETS
13.80%
Growth Rates
1Year 13.80%
3Years 10.80%
5Years 6.83%
7Years -1.79%
10Years 0.00%
94.2 M LIABILITIES
64.51%
Growth Rates
1Year 64.51%
3Years 61.01%
5Years 29.45%
7Years 28.76%
10Years 0.00%
13.3 M EQUITY
-64.21%
Growth Rates
1Year -64.21%
3Years 27.45%
5Years 16.03%
7Years -25.64%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet scPharmaceuticals Inc.
image
Current Assets 106 M
Cash & Short-Term Investments 75.7 M
Receivables 11.7 M
Other Current Assets 18.5 M
Non-Current Assets 1.67 M
Long-Term Investments 0
PP&E 1.33 M
Other Non-Current Assets 341 K
70.36 %10.90 %17.18 %Total Assets$107.5m
Current Liabilities 14.9 M
Accounts Payable 3.88 M
Short-Term Debt 0
Other Current Liabilities 11 M
Non-Current Liabilities 79.3 M
Long-Term Debt 51.4 M
Other Non-Current Liabilities 28 M
4.12 %11.67 %54.51 %29.70 %Total Liabilities$94.2m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 75.7 46.8 71.1 74.3 105.3 72.8 89.7 118.3 39.3 1.6
Short Term Investments 0 29.2 47.1 1.0 33.3 0 0 0 0 0
Receivables 11.7 4.5 0 0 0 0.3 0.5 0.7 0.3 0.1
Inventory 13.9 8.8 1.2 0 0 2.4 1.6 0.8 0.1 0.1
Other Current Assets 4.6 3.6 2.5 3.0 2.7 2.7 1.9 0.9 0.1 0.1
Total Current Assets 105.8 92.9 123.3 78.3 107.8 75.6 91.9 119.9 39.7 1.8
PP&E 1.3 1.5 0.6 0.5 0.9 1.3 1.7 2.0 26 K 23 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0.2 0.2 0 0 0 0
Other Long Term Assets 0.3 82 K 0.3 0.3 0.1 0.1 0.2 0.2 6 K 5 K
Other Assets 0 0 0 0 0 0 0 0 0 0
Total Assets 107.5 94.5 124.2 79.0 109.0 77.3 93.8 122.0 39.8 1.8
LIABILITIES
Accounts Payable 3.9 4.0 1.5 0.5 1.7 1.1 0.6 1.6 1.5 0.7
Short Term Debt 11.2 23.2 28.3 33.6 37.4 38.4 17.1 11.1 10.8 4.3 2.9 1.7 3.5 1.1 1.5
Other Current Liabilities 109.7 39.6 43.7 44.9 33.9 35.6 22.9 20.2 18.0 9.8 5.8 5.2 3.9 5.0 8.0
Total Current Liabilities 210.3 159.4 160.9 164.0 136.2 114.4 73.0 56.4 43.6 22.2 15.5 12.0 13.1 12.1 15.6
Long Term Debt 241.6 205.5 39.7 144.2 315.6 367.4 29.8 57.4 21.6 6.4 3.4 2.5 3.9 3.9 4.9
Deferred Tax Income 0 2.8 6.9 25.4 27.8 53.3 16.2 10.9 8.4 1.6 0 0 0 0 27 K
Other Liabilities 30.5 97.7 34.0 3.7 35.3 55.4 2.9 0.9 1.9 0.8 0.9 1.6 1.6 1.5 2.1
Total Liabilities 482.3 394.8 241.5 337.2 487.1 537.2 121.9 125.7 75.5 31.0 19.8 16.1 18.6 17.5 22.7
EQUITY
Common Stock 0.7 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 81 K 58 K 55 K 26 K 27 K 22 K
Retained Earnings 294.5 267.4 222.8 172.8 125.7 104.6 80.9 54.0 30.0 18.4 9.9 5.0 2.3 1.0 (0.2)
Other Accumulative Comprehensive Income/Loss (0.7) 18 K 0 0 0 0 (10.4) (6.1) (4.5) (3.0) (2.4) (2.0) (1.8) 0 2 K
Total Equity 833.0 775.8 694.2 624.7 394.1 356.0 317.5 180.1 148.2 80.8 35.6 28.8 11.4 10.5 9.7
Total Liabilities and Equity 1 315.4 1 170.6 935.7 961.9 881.2 893.1 439.4 305.8 223.7 111.8 55.4 44.9 30.0 28.0 32.3
SHARES OUTSTANDING
Common Shares Outstanding 61.6 241.4 236.1 226.2 197.8 193.9 175.9 162.9 146.0 108.4 81.6 58.6 64.0 88.7 88.7